H1B Salary Data

Home › Employers › Mercy Physicians Associates, Inc.

Mercy Physicians Associates, Inc.: H-1B salaries and sponsorship

Mercy Physicians Associates, Inc. filed 3 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 3. Median offered salary: $278,356.

Applications (LCAs)3
Certified3
Employer addressCedar Rapids, IA
H-1B dependent employerNo
Median offered salary$278,356
Middle half of salaries$270,287–$350,558
10th–90th percentile$265,446–$393,879

Does Mercy Physicians Associates, Inc. sponsor H-1B visas?

Mercy Physicians Associates, Inc. filed 3 labor condition applications in fiscal years 2023–2026, the latest submitted on Dec 30, 2025. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.

Salaries by job title

Job titleLCAsMedian salary
Primary Care Physician2$270,287
Nephrologist Physician1$422,760

Applications by fiscal year

Fiscal yearLCAsMedian salary
FY20231$278,356
FY20241$422,760
FY20261$262,218

Prevailing wage levels

The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.

Where the jobs are

Occupations

Latest applications

Job titleBase salaryLocationSubmittedStart dateStatus
Primary Care Physician$262,218–$453,185Cedar Rapids, IADec 30, 2025Jul 1, 2026Certified
Nephrologist Physician$422,760–$662,624Cedar Rapids, IAFeb 15, 2024Jul 1, 2024Certified
Primary Care Physician$278,356–$428,701
Level I
Cedar Rapids, IAMar 22, 2023Jul 1, 2023Certified

Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).